emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Terumo / Quirem Medical

No EMAT : 101365
Announced Date : 15/07/2020
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Terumo

Target : Quirem Medical
Country : Netherlands
Sector of activity :
  • Health, Pharmaceuticals & Biotechnology > Biotechnology
  • Specialized Software > Business Software > Software > Medical Software
Business Description :
Co-founded by Jan Sigger and Frank Nijsen as a spin-off of the University Medical Center Utrecht (UMCU), Quirem Medical develops and commercializes the next-generation Selective Internal Radiation...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Biotechnology » = 42
  • Number of EMAT Reports / sub-sector « Medical Software » = 81
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
15/07/2020 Medtronic Medicrea International Rhône ** 101328
24/07/2020 Creo Medical Group Albyn Medical Spain ** 101285

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report